UK set to offer coronavirus vaccine shots to 16 and 17-year-olds

The UK government is soon expected to roll out Covid shots to more than a million 16 and 17-year-olds, media reports said on Wednesday.

Coronavirus, UK,
People queue in the rain to receive vaccination amid the spread of the coronavirus disease pandemic, London (Photo: Reuters)
IANS London
2 min read Last Updated : Aug 04 2021 | 4:28 PM IST

The UK government is soon expected to roll out Covid shots to more than a million 16 and 17-year-olds, media reports said on Wednesday.

The roll out is based on recommendations of the independent UK Joint Committee on Vaccination and Immunisation (JCVI), but it is not known when the jabs will start, the BBC reported.

Currently, the vaccine is offered to people aged above 12 with underlying conditions or living with others at high risk.

The JCVI had, last month, recommended Covid jabs to children aged over 12, who are at higher risk of getting ill and to those on the verge of turning 18.

But, it delayed it as it was awaiting for further reports of rare adverse events such as inflammation of heart muscles among young adults, the report said.

However, the new advice as hinted by Scotland's First Minister Nicola Sturgeon's on Tuesday, said "hoping" to receive updated advice from the JCVI on the vaccination of 16 and 17-year-olds.

Sturgeon said the UK's four chief medical officers had written to the JCVI, asking them to look again at vaccination advice for young people, the report said.

The only Covid jab currently authorised in the UK for under-18s is the Pfizer-BioNTech vaccine.

According to the Telegraph, Pfizer and Moderna vaccines would be available in line with guidance for young adults.

Countries, including the US, Canada and France, have already rolled out vaccines for people aged 12-years-old and above.

According to the latest UK government data, 88.7 per cent of people in the UK have now had one dose of vaccine, while 73 per cent have had two jabs.

--IANS

rvt/in

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: Aug 04 2021 | 4:28 PM IST

Next Story